Squarepoint’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-42,959
Closed -$305K 3055
2025
Q1
$305K Sell
42,959
-58,458
-58% -$416K ﹤0.01% 2180
2024
Q4
$1.18M Buy
101,417
+37,533
+59% +$438K ﹤0.01% 1431
2024
Q3
$1.31M Buy
63,884
+50,604
+381% +$1.04M ﹤0.01% 1315
2024
Q2
$297K Sell
13,280
-232,496
-95% -$5.2M ﹤0.01% 1970
2024
Q1
$6.76M Buy
245,776
+235,739
+2,349% +$6.49M 0.01% 589
2023
Q4
$306K Buy
+10,037
New +$306K ﹤0.01% 1947
2023
Q3
Sell
-5,314
Closed -$217K 2718
2023
Q2
$217K Sell
5,314
-268,890
-98% -$11M ﹤0.01% 2039
2023
Q1
$10.2M Buy
274,204
+183,080
+201% +$6.82M 0.04% 326
2022
Q4
$3.18M Buy
91,124
+84,834
+1,349% +$2.96M 0.01% 616
2022
Q3
$352K Buy
+6,290
New +$352K ﹤0.01% 1550
2022
Q2
Sell
-56,057
Closed -$4.07M 2473
2022
Q1
$4.07M Buy
+56,057
New +$4.07M 0.02% 550
2021
Q4
Sell
-97,871
Closed -$13.1M 2729
2021
Q3
$13.1M Buy
97,871
+90,240
+1,183% +$12.1M 0.04% 236
2021
Q2
$1.24M Buy
+7,631
New +$1.24M ﹤0.01% 1047
2021
Q1
Sell
-44,899
Closed -$2.44M 2896
2020
Q4
$2.44M Sell
44,899
-28,323
-39% -$1.54M 0.02% 676
2020
Q3
$1.46M Buy
73,222
+19,350
+36% +$385K 0.02% 766
2020
Q2
$1.13M Buy
+53,872
New +$1.13M 0.02% 860
2019
Q2
Sell
-68,150
Closed -$1.16M 2495
2019
Q1
$1.16M Sell
68,150
-7,349
-10% -$126K 0.01% 1020
2018
Q4
$1.03M Buy
75,499
+42,999
+132% +$587K 0.01% 895
2018
Q3
$930K Buy
32,500
+5,671
+21% +$162K 0.01% 1025
2018
Q2
$734K Sell
26,829
-16,571
-38% -$453K 0.01% 1017
2018
Q1
$915K Buy
43,400
+10,917
+34% +$230K 0.01% 836
2017
Q4
$624K Buy
+32,483
New +$624K 0.01% 1060